Piper Sandler analyst Yasmeen Rahimi upgraded Korro Bio (KRRO) to Overweight from Neutral with a price target of $30, up from $11.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRRO:
- Midday Fly By: AT&T reports Q4 beat, Amazon cuts 16,000 jobs
- Oppenheimer upgrades Korro Bio to Outperform as KRRO-121 offers fresh story
- Korro Bio upgraded to Outperform from Perform at Oppenheimer
- Korro Bio upgraded to Overweight from Neutral at Cantor Fitzgerald
- Korro Bio price target raised to $10 from $7 at Clear Street